🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

TAMBE Japan Post-Marketing Surveillance

Recruitingn/aAges any - anyAllW.L.Gore & Associates
NCT07147569 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

To evaluate the safety and efficacy of multi component system (TAMBE device) including GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis (Aortic Component; AC) under post-marketing use.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Patients who were attempted to implant the AC * Thoracoabdominal aortic aneurysm * Pararenal abdominal aortic aneurysm Exclusion Criteria: * N/A
💊

What it tests

  • GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis
📍

Where

5 sites
The Jikei University Hospital
Minatoku, Japan
Nagoya University Hospital
Nagoya, Japan
Morinomiya Hospital
Osaka, Japan
Osaka International Medical & Science Center Osaka Police Hospital
Osaka, Japan
The University of Osaka Hospital
Suita, Japan
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy